GlobalData’s senior medical analyst says the ban will add to a downward trend for Illumina in the Chinese market.

The MiSeq desktop sequencer offers low throughput flowcells and long read lengths. It is best for small whole-genome sequencing, targeted gene sequencing, metagenomics, and CRISPR validation. The ...

Element Biosciences’ bid to claim a slice of a DNA sequencing technology ... instrument for next-generation sequencing (NGS), Aviti, which is a competitor to Illumina technology, like its ...

We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to ...

Kokoris came up with the idea of solving some of the noise issue of nanopore sequencing by converting DNA into larger surrogate polymers, and he cofounded sequencing company Stratos Genomics back in ...

The San Diego company also lowered its financial guidance for 2025 in response to China’s import restrictions.

Illumina is not banned from operating in the country and will continue to serve its existing customers, a company ...

Illumina Inc. (NASDAQ:ILMN), a leading provider of next-generation sequencing (NGS) technology with annual revenue of $4.37 billion, finds itself at a critical juncture as it navigates a shifting ...

Illumina, Inc., a global leader in next-generation sequencing and array-based technologies ... It focus on innovation has established us as a global leader in DNA sequencing and array-based ...

[8–12] A less known hybridization-based enrichment strategy uses filters, marked with amplicons, to capture targeted DNA libraries. [37] To achieve this, the selected target regions must be PCR ...

China has banned the import of Illumina’s next-generation sequencing ... and use a technology known as sequencing by synthesis (SBS) to enhance DNA short-read sequence generation.